The CXCL12–CXCR4 axis is known to stimulate solid tumor vascularization through the recruitment of CXCR4+ proangiogenic cells to neoangiogenic niches, [48] and has been implicated in lymphoma progression, migration, and chemoresistance [48,49,50]. The gene discussed is CXCR4; the disease is lymphoma.